AUGUST 2023

VascVersa collaborates with Hitech Health

VascVersa is delighted to partner with HiTech Health, Galway. With funding from Invest NI, VascVersa have partnered with Hitech Health, a world-leading Contract Development and manufacturing organisation (CDMO.) to support drug product formulation for VascVersa's Angicyte technology.

The HTH team's expertise is invaluable for Angicyte development as they have dedicated biomaterial expertise.
Hitech Health is excited to work with VascVersa in the development of their Angicyte technology. Our expertise in GMP analytical and process development and working in collaboration with the VascVersa experts can enable this novel vascular repair technology to be brought to patients.